OrthoPediatrics (NASDAQ:KIDS) Sees Unusually-High Trading Volume – What’s Next?

Posted by George Bondi on Oct 23rd, 2026

OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) saw an uptick in trading volume on Wednesday. 334,912 shares traded hands during trading, an increase of 89% from the previous session’s volume of 176,969 shares. The stock last traded at $23.5170 and had previously closed at $23.50.

Analyst Ratings Changes

Several brokerages have recently commented on KIDS. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. Truist Financial raised shares of OrthoPediatrics to a “hold” rating in a research report on Thursday, October 1st. Piper Sandler restated an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. BTIG Research reaffirmed a “buy” rating and issued a $29.00 price objective on shares of OrthoPediatrics in a research report on Monday, September 14th. Finally, Needham & Company LLC upped their price objective on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, OrthoPediatrics has an average rating of “Moderate Buy” and a consensus target price of $26.50.

Check Out Our Latest Research Report on KIDS

OrthoPediatrics Trading Up 3.6%

The stock’s fifty day moving average is $23.02 and its two-hundred day moving average is $20.17. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. The business had revenue of $70.51 million during the quarter, compared to the consensus estimate of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. On average, analysts expect that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Insider Activity

In related news, major shareholder Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00. Following the sale, the insider owned 6,536,764 shares of the company’s stock, valued at approximately $150,607,042.56. The trade was a 4.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Jennifer N. Pritzker sold 326,700 shares of the company’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00. Following the completion of the transaction, the insider owned 6,536,764 shares in the company, valued at approximately $150,607,042.56. The trade was a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 2,100,000 shares of company stock valued at $46,747,931 in the last three months. Company insiders own 32.50% of the company’s stock.

Institutional Trading of OrthoPediatrics

Large investors have recently bought and sold shares of the company. Ellsworth Advisors LLC bought a new position in shares of OrthoPediatrics during the 3rd quarter worth $900,000. GAMMA Investing LLC increased its holdings in OrthoPediatrics by 70.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock worth $26,000 after acquiring an additional 481 shares during the last quarter. Squarepoint Ops LLC raised its stake in OrthoPediatrics by 95.0% in the 2nd quarter. Squarepoint Ops LLC now owns 195,468 shares of the company’s stock valued at $3,739,000 after acquiring an additional 95,230 shares during the period. Waverly Advisors LLC raised its stake in OrthoPediatrics by 6.7% in the 2nd quarter. Waverly Advisors LLC now owns 12,366 shares of the company’s stock valued at $237,000 after acquiring an additional 775 shares during the period. Finally, Nantahala Capital Management LLC bought a new stake in OrthoPediatrics in the 2nd quarter valued at about $4,636,002. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp. is a medical device company focused exclusively on developing and commercializing orthopedic products for children. The company designs implants, instruments and related technologies intended to address the distinct anatomical and clinical needs of pediatric patients, including those with congenital conditions, traumatic injuries and musculoskeletal disorders.

Its product portfolio covers pediatric trauma and deformity correction, scoliosis, limb reconstruction, sports medicine and other specialized orthopedic procedures.